FIRECREST Customer Support

Discover the value of strategic early engagement during Stacey Flattery Vice President, General Partner, speaker session on Wednesday, 15 October at 11:30am at #OCTNewEngland2025. Learn how to optimize clinical outsourc...

Women face delayed diagnoses, mischaracterized symptoms, and more years of poor health than men. But even when included in clinical trials, the tools used to measure outcomes often don’t reflect their lived experience. T...

Why do stability studies matter in early drug development? From shelf-life determination to regulatory readiness, a well-designed stability program ensures your drug product remains safe, effective, and reliable. Learn...

Finding the optimal drug formulation can be the difference between success and delay. ICON’s formulation screening and optimisation process ensures the best exposure levels—reducing trial iterations and increasing clin...

We’re looking forward to participating in and hosting C-Path's annual eCOA Consortium EU meeting on October 8–9 at ICON’s Dublin office. This meeting brings together leading eCOA experts to address key industry challen...

Cell and gene therapies offer a promising approach for the treating of autoimmune diseases, but their development presents unique challenges. Meet ICON experts at #ACR25, booth \#1501 to learn how our tailored strategi...

Visit the ICON team at #ACR25, booth 1501 to discover how our strategic solutions and innovative methods help reduce patient burden, meet enrolment targets, and accelerate access to new treatment options for autoimmune d...

TOMORROW! Join ICON experts for a live webinar covering: • Evidence-based selection of measures in obesity trials • Best practices in ensuring data quality • Streamlined operational integration for more effective clinica...

Our Taipei team has been embracing wellness, creativity, and safety through a series of engaging initiatives. From celebrating the Mid-Autumn Festival with a colorful Pomelo Painting activity, to promoting heart health ...

Drop by booth \#69 at #OCTNewEngland2025, 15– 16 October. Meet the ICON experts to explore new solutions to common issues within clinical trials. Learn how we can simplify processes to help you meet critical milestones, ...

Drop by booth #69 at #OCTNewEngland2025, 15– 16 October. Meet the ICON experts to explore new solutions to common issues within clinical trials. Learn how we can simplify processes to help you meet critical milestones, o...

Despite increased female participation, most Clinical Outcome Assessments (COAs) are still designed around male biology. A recent analysis found that less than 10% of COAs were developed with female-specific populations....